Attali P, Prod'homme S, Pelletier G, Papoz L, Buffet C, Etienne J P
Gastroenterol Clin Biol. 1985 May;9(5):396-402.
The authors report the clinical and biological features in 197 patients with hepatocellular carcinoma seen in two French hospitals. Mean age was 63 +/- 12 years. Eighty-nine per cent were men. Cirrhosis was present in 88 p. 100. Alcoholic liver disease was associated with hepatocellular carcinoma in 71.5 p. 100. At the time of diagnosis, ascites was present in 62 p. 100 of the patients, jaundice in 49 p. 100, encephalopathy in 20 p. 100 and gastrointestinal bleeding in 12.5 p. 100. Twenty patients (10 p. 100) did not have any of these complications. An increase in serum gammaglutamyl transpeptidase and ASAT was the most frequent biological abnormality observed in 96 and 94 p. 100 of patients respectively. Hypercalcemia and a high hematocrit were present in 5 and 6 p. 100 of patients respectively. Serum HBs Ag (RIA) was present in 17.5 p. 100 of patients, anti-HBc in 50 p. 100 and anti-HBs in 33.5 p. 100; 38.5 p. 100 of patients had no serum HBV marker. Serum alphafetoprotein levels were higher than 20 ng/ml, 250 ng/ml and 1,000 ng/ml in 76.5 p. 100, 43.5 p. 100 and 33 p. 100 of patients respectively. There were no relationships between the presence of serum markers of HBV or high alphafetoprotein levels and clinical and biological data. These results confirm that the clinical, biological and virological aspects of hepatocellular carcinoma in France are similar to those reported in other western countries.
作者报告了在两家法国医院就诊的197例肝细胞癌患者的临床和生物学特征。平均年龄为63±12岁。89%为男性。88%的患者存在肝硬化。71.5%的肝细胞癌与酒精性肝病相关。诊断时,62%的患者有腹水,49%有黄疸,20%有肝性脑病,12.5%有胃肠道出血。20例患者(10%)没有这些并发症中的任何一种。血清γ-谷氨酰转肽酶和谷草转氨酶升高是最常见的生物学异常,分别在96%和94%的患者中观察到。5%的患者有高钙血症,6%的患者有高血细胞比容。17.5%的患者血清乙肝表面抗原(RIA法)阳性,50%抗-HBc阳性,33.5%抗-HBs阳性;38.5%的患者没有血清乙肝病毒标志物。76.5%、43.5%和33%的患者血清甲胎蛋白水平分别高于20 ng/ml、250 ng/ml和1000 ng/ml。乙肝病毒血清标志物的存在或高甲胎蛋白水平与临床和生物学数据之间没有关联。这些结果证实,法国肝细胞癌的临床、生物学和病毒学特征与其他西方国家报道的相似。